KR, M., R, F., JE, H., J, X., S, D., L, M., . . . T, K. (2024). Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy-Induced Immune-Related Adverse Events in Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 30(19), 4412. https://doi.org/10.1158/1078-0432.CCR-24-0900
Chicago Style (17th ed.) CitationKR, Monson, et al. "Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy-Induced Immune-Related Adverse Events in Melanoma." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 30, no. 19 (2024): 4412. https://doi.org/10.1158/1078-0432.CCR-24-0900.
MLA (9th ed.) CitationKR, Monson, et al. "Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy-Induced Immune-Related Adverse Events in Melanoma." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 30, no. 19, 2024, p. 4412, https://doi.org/10.1158/1078-0432.CCR-24-0900.
